Cargando…
Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ
BACKGROUND: This study compared the recurrence risk of single versus dual adjuvant radiotherapy (RT) and hormonal therapy (HT) following breast-conserving surgery (BCS) in patients with hormone receptor-positive ductal carcinoma in situ (DCIS). METHODS: This retrospective cohort study used the Taiwa...
Autores principales: | Tsai, Chi-Jui, Huang, Ho-Yin, Chen, Fang-Ming, Yang, Yi-Hsin, Chen, Li-Chia, Hsieh, Kun-Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797251/ https://www.ncbi.nlm.nih.gov/pubmed/35089956 http://dx.doi.org/10.1371/journal.pone.0262934 |
Ejemplares similares
-
Breast Ductal Carcinoma In Situ: A Literature Review of Adjuvant Hormonal Therapy
por: Kinsey-Trotman, Stephen, et al.
Publicado: (2016) -
Interruption and Non-Adherence to Long-Term Adjuvant Hormone Therapy Is Associated with Adverse Survival Outcome of Breast Cancer Women - An Asian Population-Based Study
por: Hsieh, Kun-Pin, et al.
Publicado: (2014) -
Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast
por: Boland, G P, et al.
Publicado: (2003) -
Treatment results in patients with ductal carcinoma in situ treated with adjuvant radiotherapy
por: GÜZELÖZ, Zeliha, et al.
Publicado: (2019) -
Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma
por: Sugiura, Teiichi, et al.
Publicado: (2020)